No Data
Baird Maintains Healthpeak Properties(DOC.US) With Buy Rating, Cuts Target Price to $22
Argus Research Maintains Healthpeak Properties(DOC.US) With Buy Rating, Cuts Target Price to $25
Director Makes Bold Move With Major Stock Purchase in Healthpeak Properties
Healthpeak Properties Price Target Maintained With a $25.00/Share by Argus Research
Healthpeak Properties Reports Insider Buying Worth $630K
Baird Adjusts Price Target on Healthpeak Properties to $22 From $24, Maintains Outperform Rating